ENDO

Related by string. Endo * * Endo Pharmaceuticals Hld ENDP . guesswork Koji Endo . Koji Endo managing . Koji Endo . Koji Endo auto . Endo Pharmaceuticals ENDP . Endo Pharmaceuticals NASDAQ ENDP . Endo Pharmaceuticals Nasdaq ENDP . Yasuhito Endo Gamba Osaka . analyst Koji Endo . Endo Pharmaceuticals Holdings . Ethicon Endo Surgery . PRNewswire FirstCall Endo Pharmaceuticals *

Related by context. All words. (Click for frequent words.) 64 Late Breaker 63 Endocrine Society Annual Meeting 61 ASCO GU 61 ASBMR 61 Rheumatology Annual 61 Chemotherapy ICAAC 60 Clinical Oncology Annual Meeting 60 Digestive Disease Week 60 Therapeutics TCT 60 AACR San Antonio 60 Oncology ASTRO 60 Hematology Meeting 60 Digestive Disease Week DDW 59 Gastrointestinal Cancers Symposium 59 Rheumatology ACR Annual 59 #th Interscience Conference 59 Oral Presentation 59 #th Annual Interscience 59 AAO HNSF Annual Meeting 59 nd Annual Meeting 59 AACR NCI EORTC 59 ASH Annual Meeting 59 Annual Transcatheter Cardiovascular 59 Opportunistic Infections CROI 59 AUA Annual Meeting 59 Hematology ASH Annual Meeting 59 Poster Presentations 59 Poster Presentation 58 Podium Presentation 58 AASLD 58 Nephrology Renal Week 58 AABB Annual Meeting 58 Gene Therapy ASGT 58 BIO InvestorForum 58 Society CTOS 58 Announces Poster Presentations 58 Cancer iSBTc 58 Breast Cancer Symposium 57 Clinical Oncology ASCO Annual 57 annual Transcatheter Cardiovascular 57 ICAAC IDSA 57 Biological Therapy 57 ICAAC 57 Cancers Symposium 57 liposome injection 57 Preclinical Study 57 Prostate Cancer Symposium 57 SABCS 57 Interventional Radiology SIR 57 transthyretin TTR mediated amyloidosis 57 Antimicrobial Agents 57 CROI 57 Molecular Medicine Tri 57 Liver Meeting 57 Presents Preclinical 57 Hematology Annual Meeting 57 st Annual Meeting 57 PRNewswire FirstCall Amylin Pharmaceuticals 57 Cardiovascular Therapeutics 56 Hematology ASH 56 Vascular Biology ATVB 56 AHA Scientific Sessions 56 LibiGel ® 56 AACR Meeting 56 Therapeutic Radiation 56 Abstract Number 56 Scientific Meeting 56 Inc. Nasdaq AMLN 56 Annual Scientific Sessions 56 Digestive Diseases Week 56 PSORIASIS 56 ACR ARHP 56 AASLD Meeting 56 Therapeutics TCT scientific 56 ASCO Annual Meeting 56 ECTRIMS 56 AAPS Annual Meeting 56 AACR #st Annual Meeting 56 Cambridge Healthtech Institute 56 #nd Annual Meeting 56 Ophthalmic Drugs Advisory 56 ASTRO Annual Meeting 56 ASCO GI 56 Transcatheter Cardiovascular Therapeutics TCT 55 #nd EORTC NCI 55 Phase 2b Clinical Trial 55 Connective Tissue Oncology 55 CTRC AACR San Antonio 55 #st Annual Meeting 55 ACR ARHP Annual 55 Poster Discussion 55 CLEO QELS 55 Molecular Targets 55 ADA Scientific Sessions 55 PRNewswire FirstCall Tercica 55 Pediatric Academic Societies PAS 55 Controlled Release 55 BIOCOM Investor Conference 55 Nasdaq CYTX 55 Genitourinary Cancers Symposium 55 Clinical Trial Results 55 Inc. Nasdaq IMGN 55 Prospective Randomized 54 FDA APPROVES 54 Human Genetics ASHG 54 Nephrology ASN Renal 54 Endocrine Society ENDO 54 Transcatheter Cardiovascular Therapeutics 54 & OTO EXPO 54 America HFSA 54 Canaccord Adams Hepatitis C 54 Pharmaceutical Scientists AAPS 54 Oral Fingolimod 54 BioProcess International 54 NYSE Alternext ULU 54 CIMZIA TM certolizumab pegol 54 Frankfurt XMP 54 Aflibercept 54 Diabetic Macular Edema DME 54 pan HDAC inhibitor 54 Nasdaq SNSS 54 UEGW 54 Free Full Text 54 Endocrine Society #nd 54 IN PATIENTS WITH 54 SAWC WHS 54 Breaking Clinical Trials 54 Recombinant Human 54 lexidronam injection 54 Tanespimycin 54 Interventions SCAI 54 Pediatric Academic Society 54 ASCO Breast Cancer 54 Guanilib 54 Nasdaq IDRA today 54 Vaccine Adjuvant 54 DDW ® 54 abstracts summarizing 54 AACR IASLC Joint 54 Preclinical Data 54 Antiviral Therapy 54 EUROGIN 54 NYSE Amex RGN 54 Selective Cardiac Myosin 54 Annual ICAAC 54 Heart Failure Society 54 RDEA 54 Phase 2a Study 54 entitled Synergistic 54 Nasdaq ENZN 54 See CLINICAL PHARMACOLOGY 54 ECCMID 54 Keystone Symposia 54 ESTRO 54 Nasdaq BSTE 54 NASDAQ LIPD 54 orally inhaled migraine 53 CARDIOVASCULAR 53 Arteriosclerosis Thrombosis 53 ARVO 53 Clinical Chemistry AACC 53 Phase 2a Trial 53 Double Blind Placebo 53 Selective Cardiac Myosin Activator 53 Nasdaq GNTA 53 Pediatric Academic Societies 53 NASDAQ EXAS 53 Gastroenterology ACG Annual 53 Inflammatory Arthritis 53 Presents Preclinical Data 53 verteporfin 53 AAN Annual Meeting 53 Reports Preclinical Data 53 Oligonucleotides 53 Poster Session 53 Endocrine Society #st 53 dual endothelin receptor antagonist 53 MATCHED 53 Nasdaq ALXN 53 Dermatologic 53 FOLOTYN ® 53 preclinical efficacy 53 EORTC NCI 53 Fondaparinux 53 Therapeutic Radiology 53 Tumor Microenvironment 53 Initiates Clinical Trial 53 Cardiovascular Anesthesiologists 53 Abstract Accepted 53 Stem Cell Research ISSCR 53 EASL 53 Tolvaptan 53 Neurology AAN 53 Gastroenterology ACG 53 Elvitegravir 53 Dendritic Cells 53 Hsp# Inhibitor 53 Endoscopic Surgeons SAGES 53 Metabolic Disease 53 histone deacetylase HDAC inhibitor 53 ASGT 53 Beneficial Effects 53 Inhalation Solution 53 System Pharmacists ASHP 53 II Clinical Trial 53 Plastic Surgeons ASPS Plastic 53 Zenvia Phase III 53 Vascular Annual Meeting 53 #:#-# [035] 53 Phase Ib Clinical Trial 53 Scientific Sessions 53 SAEM Annual Meeting 53 NASDAQ PCYC 53 Radiation Oncology ASTRO 53 Pivotal Clinical Trial 53 Cardiovascular Renal Physiology 52 QLT# 52 OTCBB AOLS 52 Microbiology ASM 52 GLOBE NEWSWIRE Integra LifeSciences 52 non nucleoside inhibitor 52 Nephrology ASN 52 TXPO 52 Gynecologic Investigation 52 Crit Rev 52 Traficet EN 52 Rheumatology Annual Meeting 52 Midyear Clinical Meeting 52 Active Biotech NASDAQ OMX 52 American Roentgen Ray 52 ACADIA Pharmaceuticals 52 Bazedoxifene 52 PAINWeek 52 Arch Neurol 52 Nordic ACTI 52 ISTO Technologies Inc. 52 Targeted Anticancer Therapies 52 Cancer Immunotherapy 52 PRECISE 52 HFSA Annual 52 Targanta Therapeutics Corporation 52 Lysosomal Disease Network 52 Phase III ALLEGRO 52 Hagop M. 52 fosbretabulin 52 GENENTECH 52 Hypertension ASH 52 ANN INTERN MED 52 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 52 Phase 2a Clinical Trial 52 Movement Disorder 52 Neuro Oncology SNO 52 & Immunology AAAAI 52 FIBROMYALGIA 52 Clinical Oncology Gastrointestinal Cancers 52 OSIR 52 Clinical Oncologists 52 #:#-# [031] 52 NASDAQ BMTI 52 histone deacetylase inhibitor 52 Ocular Diseases 52 clevidipine 52 Nasdaq BNVI 52 ® DDW 52 CHEST 52 Solorel TM 52 Microwave Ablation System 52 CELGENE 52 GTCbio 3rd 52 R roscovitine 52 NASDAQ IDRA 52 abstr 52 Cell Biology ASCB 52 OTO EXPO 52 Immunologists 52 Scientific Session 52 Nasdaq IMGN 52 Personalized Immunotherapy 52 Breast Cancer Symposium SABCS 52 Cell Transplant 52 interstitial cystitis IC 52 urethral bulking agent 52 VEITHsymposium 52 Acute Ischemic Stroke 52 HDL Selective Delipidation 52 Presents Positive 52 AAPM 52 Cachexia 52 ACC.# 52 Neoplasia 52 Ocular Pharmacology 52 Acute Heart Failure 52 NASDAQ CXSP announced 52 Oral Presentations 51 HDAC Inhibitors 51 REGiMMUNE 51 Inc. Nasdaq VRUS 51 GASTRO 51 ASCRS 51 EOquin TM 51 ISPOR 51 immunotherapeutic vaccine 51 Inc. Nasdaq INFI 51 Metastatic Melanoma 51 Pyridorin 51 PRNewswire FirstCall Bionovo 51 Pulmonary Hypertension 51 Nasdaq MBRX announced 51 Nasdaq PCYC 51 THYROID 51 Xcytrin R 51 AACR Annual Meeting 51 Liver EASL 51 Novel Inhibitor 51 reflux esophagitis 51 ATVB 51 LD Micro 51 ABSTRACTS 51 PRNewswire FirstCall Kensey Nash 51 Nephrology Annual Meeting 51 STENT 51 sorafenib tablets 51 Biologic Therapy 51 ASCO abstract 51 PSN# [002] 51 Autoimmunity 51 AOSSM 51 Environ Health Perspect 51 Anesthesiologists ASA Annual Meeting 51 Spine Society 51 Ophthalmology ARVO 51 Nasdaq KNSY 51 Neurology Annual Meeting 51 Rheumatology ACR 51 League Against Rheumatism 51 Relapsing Multiple Sclerosis 51 Nasdaq CYCC Nasdaq CYCCP 51 Neurotology 51 Meets Primary Endpoint 51 JAK2 Inhibitor 51 EFNS 51 Neurosurg 51 Hand ASSH 51 Nasdaq SGMO announced 51 Inc. Nasdaq AVRX 51 Inc. Nasdaq ATHX 51 Preclinical Studies 51 Neuropathic Pain 51 Biodefense Vaccines 51 Diabetic Macular Edema 51 Biophysical Society 51 Antiviral Activity 51 J Am Coll 51 Alexion Pharmaceuticals Inc 51 Symposium SABCS 51 DU #b 51 gastrointestinal stromal tumors GIST 51 Combination REOLYSIN R 51 Therapeutics Roundtable 51 Medical Oncology ESMO 51 EORTC NCI AACR Symposium 51 NATRECOR ® 51 DUROS 51 Completes Patient Enrollment 51 Inc. Nasdaq BNVI 51 Hana Biosciences 51 Inc. Nasdaq BIOD 51 ABRF 51 HDAC Inhibitor 51 ASCO Genitourinary Cancers Symposium 51 HUMAN GENOME SCIENCES 51 Androgen Receptor 51 Anesthesiologists Annual Meeting 51 Windhover Therapeutic Area 50 Mineral Research ASBMR 50 Ocular Inflammation 50 Inc. Nasdaq SEPR 50 AAAS Annual Meeting 50 CANCERS 50 Logo http:/www.newscom.com/cgi-bin/prnh/#/Chai Garam 50 NSTI Nanotech 50 PRNewswire FirstCall Genaera 50 Thoracic Surgeons STS 50 Aphton Corporation 50 ASTMH 50 Prolongs Survival 50 Natalizumab 50 Solid Tumors 50 antibody blinatumomab MT#/MEDI-# 50 Long Awaited Reality 50 metastatic castration resistant 50 Clinical Trial Data 50 BiTE R 50 SKIN CANCER 50 Female Urology 50 Medicine AAPM 50 Nephrol 50 SPIE Photonics West 50 orally administered inhibitor 50 PRNewswire FirstCall Genta Incorporated 50 microsphere therapy 50 ABI OTCBB AMAR 50 KRN# 50 HEART FAILURE 50 Innate Immunity 50 Rexahn Pharmaceuticals 50 oral prodrug 50 Proc Am Soc 50 Novel Oral 50 Carfilzomib 50 Breast Surgeons 50 #-# Full Text 50 targeting CD# 50 Idiopathic Pulmonary Fibrosis 50 Nat Genet 50 Neurological Surgeons AANS 50 Gastrointestinal Endoscopy ASGE 50 Otology 50 phase IIIb 50 Immunotherapeutic 50 ongoing Phase 1b 50 Vical Incorporated 50 GTCbio 50 Anti Infective Drugs 50 BioCentury Future Leaders 50 Central Retinal Vein 50 pralatrexate injection folate analogue 50 Hyperlipidemia 50 HuMax CD4 50 Inc. Nasdaq TRCA 50 ORAL Sync 50 Canaccord Genuity Musculoskeletal 50 Archexin 50 NASDAQ INHX 50 Eluting Coronary Stent System 50 Autoimmune Diseases 50 Blinatumomab 50 Annual Meeting 50 Anti Tumor 50 Biomolecular Sciences SBS 50 USpella 50 International Papillomavirus 50 Inc. Nasdaq RDYN 50 Molecular Cancer 50 Safinamide 50 MULTIPLE MYELOMA 50 Lung Transplantation 50 Annual Interscience Conference 50 Biophysical Society Annual Meeting 50 Breaking Clinical Trial 50 AAG geldanamycin analog 50 Hedgehog Pathway Inhibitor 50 PRNewswire FirstCall Nektar Therapeutics 50 Mass Spectrometry ASMS 50 ASMS Conference 50 EORTC NCI AACR 50 Cardiol 50 mitogen activated ERK kinase 50 Therapeutic Targets 50 ERA EDTA 50 #:# -# [005] 50 Immunology Annual Meeting 50 Clinical Efficacy 50 DIAGNOSTIC 50 Cardiology ESC Congress 50 Oncologic 50 OTCBB AOLS announced 50 Anesthesiologists ASA 50 delafloxacin 50 SCAI Annual 50 eniluracil 50 NASDAQ CYTK announced 50 Ohr Pharmaceutical Inc. 50 Pooled Analysis 50 resolvin 50 Investigative Dermatology 50 essential thrombocythemia ET 50 ARQL 50 Clavis Pharma ASA 50 PRNewswire FirstCall Oncothyreon 50 candesartan cilexetil 50 evaluating tivozanib 50 CTI Nasdaq 50 Liposomal 50 www.aacr.org 49 International OARSI 49 OVARIAN CANCER 49 Hematological Malignancies 49 Alzheimer Disease ICAD 49 PRNewswire FirstCall Pharmacopeia 49 Frozen Shoulder syndrome 49 Endovascular Therapy 49 Cardiovascular Interventions 49 JAK2 inhibitor 49 ISHLT 49 VEITHsymposium TM 49 orthopedic biosurgery company 49 HCV Protease Inhibitor 49 Clinical Dermatology 49 Elagolix 49 thetreatment 49 JMP Securities Healthcare 49 INSPIRE Trial Phase III 49 NASDAQ TARG 49 PNP inhibitor 49 Nutracon 49 Inc. NASDAQ AGIX 49 NASDAQ ARRY 49 Minimally Invasive Spine Surgery 49 Ann Intern Med 49 selective inhibition 49 Inflammatory Bowel Diseases 49 ECCO ESMO 49 #:# -# [003] 49 Suppl. 49 Antibody Engineering 49 Inc. Nasdaq CRTX 49 selective kinase inhibitor 49 Adjunctive 49 Inc. Amex ILE 49 BioContact Quebec 49 Inc. Nasdaq ANDS 49 Drug Eluting Stents 49 targeted antifolate 49 ASM Biodefense 49 Surgical Pathology 49 carotid artery stenting CAS 49 Urocortin 2 49 IEEE MTT S 49 Oncol 49 Molecular Pathology AMP 49 R lenalidomide 49 OneMedPlace Finance Forum 49 Clinical Oncology ASCO 49 Drugs Affecting Lipid 49 Recurrent Chest Wall 49 www.regenerx.com 49 Gynecol Oncol 49 LEVAQUIN 49 Endovascular Therapy ISET 49 Pluristem Therapeutics 49 seliciclib CYC# 49 AACR 49 kidney urologic 49 Osseointegration 49 MEDICAL INC 49 HuMax EGFr 49 Refractory Angina 49 vinca alkaloid 49 RE LY trial 49 Interventional Radiological Society 49 Cytori NASDAQ CYTX 49 ALLSCHWIL BASEL SWITZERLAND 49 Liver Diseases AASLD 49 SMOKING CESSATION 49 Chemophase 49 Brentuximab Vedotin SGN 49 Arch Intern Med 49 Clinical Endocrinologists AACE 49 Inc. NASDAQ HEPH 49 Dr. Gulfo 49 Experimental Biology EB 49 acute PAO 49 Anticoagulation 49 Nasdaq NFLD announced 49 EuroPCR 49 ASGCT 49 GRNCM1 49 Inc. NASDAQ AXYX 49 CONQUER 49 Interscience Conference 49 Photodynamic Therapy 49 PUTTING BREAKING NEWS 49 Tissue Repair 49 Minimally Invasive Gynecology 49 FOOD EXPO 49 CERVICAL 49 Ampligen ® 49 EXPAREL ™ 49 J Neurosurg 49 radezolid 49 NOVARTIS 49 CYT# potent vascular disrupting 49 Chest Physicians CHEST 49 Microplasmin 49 bazedoxifene conjugated estrogens 49 TRANSFORMS 49 Neck Surgery Foundation 49 ALN TTR 49 Capsule Endoscopy 49 Initiated Phase 49 Autoimmune Disease 49 IL# PE#QQR 49 #rd Annual CTRC 49 Cardiology ESC 49 Ankle Society AOFAS 49 HEART DISEASE 49 Canaccord Genuity Growth 49 Menopause Society NAMS 49 ASN Renal Week 49 CardioTech International 49 proteasome inhibitor 49 Clinical Trials Update 49 First Patient Enrolled 49 Molecular Origins 49 Cardiology ACC 49 PROSTATE 49 Multiple Myeloma MM 49 PRNewswire FirstCall Ardea Biosciences 49 PROVENGE sipuleucel T 49 Needham Growth Stock 49 sulodexide 49 MEND CABG 49 Retrovirus Conference 49 preclinical pharmacokinetic 49 Heart Failure Patients 49 #:#-# [024] 49 Haemostasis ISTH 49 Inc. OTCBB SYBD 48 Idenix Pharmaceuticals 48 Pharmacodynamics 48 NAREIT Investor 48 Lisofylline 48 Wound Ostomy 48 anticancer compound 48 Trofex 48 iSBTc 48 Liver Diseases 48 compound AEZS 48 American Thoracic Society 48 Phase Ib study 48 Glufosfamide 48 Myelodysplastic Syndromes 48 Inc. OTCBB SNWV 48 EACTS 48 Maven Semantic 48 Antimicrobial Chemotherapy 48 Observational Study 48 registrational Phase 48 Applied Spectroscopy 48 Cardiometabolic 48 HIF PH inhibitors 48 Nasdaq CLSN 48 PROSTASCINT R 48 ThinkEquity Partners Growth 48 Bucindolol 48 Gastrointestinal Cancer 48 TÎ ² 4 48 Cardiostim 48 Carotid Stenting 48 substudy 48 International Myeloma Workshop 48 Neuropsychopharmacology 48 Semafore Pharmaceuticals 48 Antisense 48 International Microwave Symposium 48 CINN 48 STEM CELLS 48 ISTH 48 Neural Repair 48 Ophthalmology AAO 48 Room #AB [002] 48 www.asco.org 48 VEITHsymposium ™ 48 AACR #nd Annual Meeting 48 Dermatology AAD 48 Ranolazine 48 Aggressive Reduction 48 GW# [003] 48 Spine Arthroplasty Society 48 Phase #/#a trial 48 Diabetic Foot 48 FASEB J. 48 Antibody Therapeutics 48 DEERFIELD Ill. Business Wire 48 recurrent glioblastoma multiforme 48 Nasdaq GENR 48 Neulasta ® 48 Oncologic Drugs Advisory 48 Nasdaq INCY announced 48 radioimmunotherapy RIT 48 Malignant Mesothelioma 48 CEQ# 48 Epeius Biotechnologies Corporation 48 WOCN 48 Retroviruses 48 Oligonucleotide Therapeutics Society 48 Neuropsychopharmacology ACNP 48 Omacetaxine 48 th Annual Interscience 48 Glycobiology 48 Urodynamics 48 mGluR5 negative 48 ViroPharma Incorporated 48 Bioral ® 48 Retina Specialists 48 Respiratory Viral Infections 48 PRNewswire FirstCall Pressure BioSciences 48 ThermoDox R 48 CTAP# Capsules 48 J Clin Endocrinol Metab 48 HDL Mimetic Peptide 48 JAK1 48 recurrent glioma 48 Br J Haematol 48 Anticancer Drug 48 J Natl Cancer Inst 48 ST Elevation Myocardial 48 LabAutomation# 48 phase IIb study 48 Introgen Therapeutics Inc. 48 th Interscience Conference 48 AAGL 48 Aplidin R 48 Phase #b/#a clinical 48 GOUT 48 Pharmacother 48 Advanced Heart Failure 48 WEIGHT LOSS 48 Belimumab 48 oral rivaroxaban 48 SA FC# 48 Bortezomib 48 Valsartan 48 PEDIATRIC 48 Gynecologic Cancer Society 48 Onconova Therapeutics Inc. 48 Inc. NASDAQ ONTY 48 Apoptone 48 RENAL 48 Needham Biotechnology 48 midstage clinical 48 ligand TRAIL 48 Medicine ISMRM 48 depsipeptide 48 Inc. Nasdaq OPTR 48 Developmental Therapeutics 48 #:# -# [004] 48 Clinical Therapeutics 48 HCV polymerase inhibitors 48 J Clin Oncol 48 Endocrine Surgery 48 SfN 48 Acute MI 48 metformin accumulation 48 #:#-# [023] 48 DIA Annual Meeting 48 Photocure ASA 48 IMS# 48 Sidoti Emerging 48 RNAi therapeutic targeting 48 MGd 48 RNAi Therapeutic 48 TLR antagonists 48 AACR symposium 48 Am J Epidemiol 48 ACCOMPLISH 48 Investor Luncheon 48 Pharmacokinetics 48 Bendavia 48 SIX ATLN 48 Kinase Inhibitor 48 anti amnesic 48 Chemokine Therapeutics 48 Patient Registry 48 Fifth Decennial International 48 SID Display Week 48 DRUG DISCOVERY 48 Acute Myocardial Infarction 48 Histocompatibility 48 ASCB 48 eCardio Diagnostics 48 novel immunotherapeutic 48 mGlu2 3 48 Biotech Showcase 48 SUCCEED trial 48 ExTRACT TIMI 48 BiTE Antibody 48 Endocrine Practice 48 HCV SPRINT 48 Hematology ASH Meeting 48 Functional Neurosurgery 48 Outcomes Research ISPOR 48 Isolaz ® 48 DJO Incorporated DJO 48 Antiviral Research 48 Trandolapril 48 pharmacokinetic PK 48 BIOSCIENCES 48 Hoyoung Huh MD Ph.D. 47 rivaroxaban Xarelto 47 Cardiology Scientific Sessions 47 WEB OF SCIENCE 47 Pediatric Radiology 47 Ann Rheum Dis 47 ANNUAL MEETING 47 Retina Specialists ASRS 47 IMGN 47 trial evaluating PRX# 47 Incisionless Surgery 47 Medicinal Chemistry Letters 47 CRLX# 47 PROSTVAC TM 47 Orthopedic Surgeons AAOS 47 PHYSICAL ACTIVITY 47 Deforolimus 47 Biomedical Optics 47 LSE ASM 47 Polyzene R F 47 Cancer Cachexia 47 Phase 1b trial 47 European CanCer Organisation ECCO 47 Physiology Seminar 47 Nasdaq VPHM 47 small molecule agonists 47 ISSWSH 47 Nuclear Cardiology 47 ASMBS 47 AACR EORTC NCI 47 NASDAQ SLXP today 47 antibody MT# 47 Peer Reviewed Journal 47 Opportunistic Infections 47 JPMorgan SMid Cap 47 HBeAg + 47 Arpida Ltd. 47 Tumor Biology 47 Radiation Oncologists 47 AAGP 47 ONCOLOGY 47 Acute Treatment 47 MEDTRONIC 47 lipidomics 47 Genvec 47 ANTEGREN 47 Novalis Circle 47 Systemic Delivery 47 AIR2 Trial 47 Glatiramer acetate 47 Sports Medicine AOSSM 47 Inc. Nasdaq SGMO 47 J Shoulder Elbow 47 CANCER TREATMENT 47 Thoracic Surgery AATS 47 CANCER RESEARCH 47 America RSNA 47 Endourology 47 aerosolized KL4 surfactant 47 ALS MND 47 Inc. OTCBB LPTN 47 REMINDER ORLive Presents 47 NEUGENE R 47 Thomas Ichim 47 BioNumerik 47 mg administered orally 47 novel VDA molecule 47 angiotensin receptor blocker ARB 47 Abstract # 47 Cylene Pharmaceuticals 47 PRNewswire FirstCall Palatin Technologies 47 ON #.Na 47 Imaging Informatics 47 lumiliximab 47 NCVH 47 HepaSphere 47 Amrubicin 47 cetuximab Erbitux 47 novel histone deacetylase 47 Endeavor Drug Eluting 47 coronary stent merged 47 PEGylated interferon beta 1a 47 Safety Tolerability 47 Tissue Engineering 47 Endologix Powerlink System 47 Inc. Nasdaq ARQL 47 worsening thrombocytopenia 47 Experimental Biology FASEB 47 HCV NS5B polymerase 47 LUNG CANCER 47 Growth Institutional Investor 47 PEG SN# 47 ELACYT 47 PRNewswire Tengion 47 Hematologic 47 RNA antagonists 47 ILLUSTRATE 47 oral proteasome inhibitor 47 Small Molecule 47 MALVERN Pa. Business Wire 47 antiproliferative effects 47 Cerebrovascular Diseases 47 Diabetes EASD 47 www.palatin.com 47 Overactive Bladder OAB 47 EFORT 47 NAREIT REITWeek 47 CRMD# 47 ZYBRESTAT TM 47 Company NASDAQ MDCO 47 Wound Healing Society 47 FOR HEALTH 47 M.D. Ph.D. 47 personalized cellular immunotherapy 47 Well Tolerated 47 Endovascular Valve Edge 47 Psychiatric Services #:#-#,# 47 DIAGNOS inc 47 Romidepsin 47 Interventional Cardiologists 47 ARBITER 47 Upregulation 47 Gynecologic Oncologists 47 Cardiovascular Disease Epidemiology 47 programs visit http:/www.bionovo.com 47 Electro Optics Society 47 Breast Surgeons ASBS 47 Aneurysm Repair 47 J Am Soc 47 Curon Medical 47 Liver Disease AASLD 47 Heart Rhythm 47 dose escalation clinical 47 N Engl J 47 THERAPIES 47 BREAST CANCER 47 Dermatological 47 BiTE antibody MT# 47 Emergency Medicine SAEM 47 NAASO 47 RADIANT 47 EULAR 47 PRNewswire FirstCall ViroPharma Incorporated 47 http:/www.palatin.com 47 EnteroMedics proprietary neuroblocking technology 47 efficacy tolerability 47 Phase III ADT 47 MTAX CTIC 47 urinary N telopeptide 47 Castration Resistant Prostate Cancer 47 ZFP Therapeutic 47 Nasdaq SMTS 47 pharmacodynamic properties 47 Fifteenth Annual 47 #:# -# [006] 47 EASD 47 darinaparsin ZIO 47 Talabostat 47 Immunology ACAAI 47 BIOTECH 47 SGX Pharmaceuticals 47 SoftScan ® 47 catheter occlusion 47 AVERROES 47 Thromb Haemost 47 Hematological 47 #:#-# [032] 47 Clinical Virology Symposium 47 ECNP 47 AAO HNS 47 Arch Surg 47 Thermo Scientific booth 47 FOLFOX6 chemotherapy regimen 47 EINSTEIN DVT 47 Randomized Double blind 47 Referenced EEG 47 antimitotic 47 Meta Analysis 47 journal Arteriosclerosis Thrombosis 47 ISPD 47 www.pranabio.com 46 Stent Thrombosis 46 Cardiovascular Horizons 46 www.labopharm.com 46 AEZS 46 Seconds Count 46 Panzem R 46 Acadia Pharmaceuticals ACAD 46 Oncolytic Viruses 46 TSX PLI ProMetic 46 CCX# 46 Atrial Fibrillation Symposium 46 recombinant tissue plasminogen 46 Thrombolytic Therapy 46 Manja Bouman CEO 46 Vulnerable Plaque 46 Minimally Invasive Cardiothoracic Surgery 46 SCHERING PLOUGH 46 Randomized Clinical Trial 46 Pivotal Trial 46 generation antisense 46 BIO# 46 SUN MAY 46 Am J Pathol 46 #:#-# [040] 46 PKC# 46 REITWeek 46 atypical Hemolytic Uremic Syndrome 46 Myelodysplastic Syndromes MDS 46 Neuropsychiatry

Back to home page